Blog - Page 3631 of 5482

WednesdayMay 12, 2010 12:22 pm

Cellceutix Corp. (CTIX.OB) Continues Development of Autism Compound, Encouraged by Large Pharmaceutical Companies Announcing Interest in Similar Compounds

Cellceutix Corp., a developer of small compounds for the treatment of cancer, autism and inflammatory diseases, issued a press release today commenting on the status of the industry in pursuing compounds addressing the core issues for developmental diseases. Cellceutix is encouraged by the recent results of a clinical study conducted by Novartis AG (NYSE: NVS). The New York Times published an article on April 29th to showcase the results from a small, overseas study for the treatment of fragile X syndrome by the Switzerland-based pharmaceutical giant. Fragile X, a genetic disorder characterized by changes in part of the X chromosome,…

WednesdayMay 12, 2010 12:14 pm

AlumiFuel Power Corp. (AFPW.OB) Subsidiary Wins Navy R&D Contract

AlumiFuel Power Inc., wholly-owned operating subsidiary of AlumiFuel Power, Corp. (“API”), www.AlumiFuelPowerInc.com, while in early production stage, is an alternative energy company with an incredibly portable niche-application hydrogen production technology based on a chemical reaction between water and aluminum, and revolutionized by the Company’s proprietary additives. API proudly announced the award of a U.S. Navy R&D contract today working in conjunction with the Rockford, Illinois-based Ingenium Technologies, Inc., the team selected for Phase 1 award by the Navy’s Small Business Technology Transfer (STTR) program. An STTR solicitation from the U.S. Department of the Navy, for a new air-independent fuel cell…

WednesdayMay 12, 2010 12:04 pm

Revolutions Medical Corp. (RMCP.OB) Expanding into Brazil via Strategic Partnership

Revolutions Medical Corp., www.RevolutionsMedical.com, provider of a variety of safety/efficiency-oriented products and services to the medical industry, such as the proprietary and FDA-approved RevVac safety syringe (a safety blood drawing device), as well as a safety IV catheter and imaging solutions for MRIs and PACS, announced the signing of an agreement of understanding today with Santa Monica Pharmaceutica Ltda for the expressed purpose of setting up a manufacturing facility in Brazil to mass produce the RevVac safety syringe for global consumption. The facility will also act as a strong foothold in the South American market for RMCP, by functioning as…

WednesdayMay 12, 2010 12:01 pm

Elephant Talk (ETAK.OB) Signs Agreement with T-Mobile

Elephant Talk Communications, Inc. announced today a Mobile Virtual Network Operating (MVNO) agreement with T-Mobile Netherlands BV. T-Mobile Netherlands BV is part of Deutsche Telekom AG, one of the world's leading companies in communications. The Hosting Agreement is to service a new MVNO initiative of T-Mobile Netherlands on the Elephant Talk Mobile Virtual Network Enabling (MVNE) platform. Through the agreement, T-Mobile will be providing new mobile services to Dutch consumers. Elephant Talk’s MVNE platform is a key component for T-Mobile to introduce these new services. With the agreement in place, T-Mobile will utilize the Elephant Talk technologies to increase functionalities…

WednesdayMay 12, 2010 11:58 am

Response Genetics, Inc. (RGDX) Signs Agreement with GlaxoSmithKline

Response Genetics Inc. is a company focused on the development and sale of molecular diagnostic tests for cancer which are based on its proprietary and patented technologies. The company's technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. The company announced recently that it has signed a non-exclusive agreement with global drug giant GlaxoSmithKline. Under the terms of the agreement, Glaxo gains certain rights to Response Genetics' proprietary PCR (polymerase chain reaction) analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Specific genetic mutations…

WednesdayMay 12, 2010 10:22 am

Micro Identification Technologies, Inc. (MMTC.OB) Video Chart for Wednesday, May 12, 2010

MMTC has made a strong move over the last 2 weeks and is once again pushed above resistance. Now we are looking for this level to hold and establish a solid uptrend for the long term. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=395 Let us hear your thoughts below:

WednesdayMay 12, 2010 10:20 am

Sun Hydraulics Corp. (SNHY) Reports First Quarter Results, Sees Recovery Strengthening

Sun Hydraulics Corp. is a leading designer and manufacturer of high-performance, screw-in hydraulic cartridge valves and manifolds for worldwide industrial and mobile markets. The company recently reported its first quarter 2010 results for the three months ended April 3, 2010. The company's net sales came in at $31.6 million, a solid increase of 25 percent from the $25.2 million reported for the three months ended March 28, 2009. Net income for Sun Hydraulics came in at $3.3 million for the period ended April 3, 2010. This is an exceptional increase of 450 percent from the $0.6 million which was reported…

WednesdayMay 12, 2010 10:17 am

ADDvantage Technologies (AEY) Announces Positive Three And Six Month Results

ADDvantage Technologies Group Inc., provider of service and equipment for the cable television industry, has announced results for the three and six month periods ending March 31, 2010. Revenue for the three month period ending 3/31/2010 was $12.1 million, compared to $10.1 million for the same period last year, representing an increase of 19%. Net income for the period (attributable to common stockholders) was $1.1 million, compared to $0.7 million for the same period last year, representing an increase of 57%. For the six month period ending 3/31/2010, revenue decreased slightly to $22.3 million from $22.9 million for the same…

WednesdayMay 12, 2010 10:16 am

Sino Assurance Inc. (SNAS) Reports Higher Net Income in First Quarter

Sino Assurance Inc. reported net income of $586,000, or $0.01 per share, for the first quarter of 2010. This compares to earnings of $14,749, or $0.00 per share, a year earlier. The company's revenue totaled $1.9 million for the quarter, compared to $727,000 in the same quarter of 2009. The management of Sino Assurance Inc. attributed the high revenue growth to the presence of higher cash balances in its cash advance guarantee business. Sino Assurance Inc. reported no short term or long-term debt as of 3/31/2010. The company had cash and equivalents of $6.8 million, but almost all the cash…

WednesdayMay 12, 2010 10:05 am

Tianyin Pharmaceutical Co., Inc. (TPI) Reports Higher Revenue and Net Income in Third Fiscal Quarter

Tianyin Pharmaceutical Co., Inc. reported net income of $15.9 million, or $0.09 per diluted share, in the third fiscal quarter of 2010. The company earned $1.9 million, or $0.08 per diluted share, in the corresponding quarter in fiscal 2009. Tianyin Pharmaceutical Co., Inc. reported revenue of $15.9 million in the third fiscal quarter of 2010. This was 60% higher than the $9.9 million reported in the same quarter last fiscal year. Management of Tianyin Pharmaceutical Co., Inc. attributed the strong revenue growth to expansion of the company’s sales channel and higher utilization of its manufacturing facility. Dr. Jiang, Guoqing, the…

Site Search

Company Search